Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Authors
Keywords
-
Journal
eLife
Volume 5, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2016-05-10
DOI
10.7554/elife.14137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
- (2016) Imke Jenniches et al. BIOLOGICAL PSYCHIATRY
- What are 'good' depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis
- (2016) Eiko I. Fried et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
- (2015) S.-H. Lee et al. JOURNAL OF NEUROSCIENCE
- Increased Basolateral Amygdala Pyramidal Cell Excitability May Contribute to the Anxiogenic Phenotype Induced by Chronic Early-Life Stress
- (2015) A. R. Rau et al. JOURNAL OF NEUROSCIENCE
- Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
- (2015) G I Papakostas et al. MOLECULAR PSYCHIATRY
- From circuits to behaviour in the amygdala
- (2015) Patricia H. Janak et al. NATURE
- Ketamine and other potential glutamate antidepressants
- (2015) Arpan Dutta et al. PSYCHIATRY RESEARCH
- Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials
- (2014) Farhad Faridhosseini et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
- (2014) Teniel S. Ramikie et al. NEURON
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
- (2014) Daniel J. Hermanson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
- (2014) Brian C. Shonesy et al. Cell Reports
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
- (2014) R J Bluett et al. Translational Psychiatry
- Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review
- (2013) G. Fond et al. ACTA PSYCHIATRICA SCANDINAVICA
- Prostamide F2αreceptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition
- (2013) Alessia Ligresti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
- (2013) Daniel J Hermanson et al. NATURE NEUROSCIENCE
- 50 years of hurdles and hope in anxiolytic drug discovery
- (2013) Guy Griebel et al. NATURE REVIEWS DRUG DISCOVERY
- Neurotherapeutic Implications of Brain-Immune Interactions
- (2013) Jennifer C Felger et al. NEUROPSYCHOPHARMACOLOGY
- Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice
- (2013) Joyonna C. Gamble-George et al. PSYCHOPHARMACOLOGY
- Amygdala FAAH and anandamide: mediating protection and recovery from stress
- (2013) Ozge Gunduz-Cinar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pharmacological enhancement of calcium-activated potassium channel function reduces the effects of repeated stress on fear memory
- (2012) Derek Atchley et al. BEHAVIOURAL BRAIN RESEARCH
- Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
- (2012) Ronald C. Kessler et al. INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH
- The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
- (2012) Piotr Gałecki et al. JOURNAL OF AFFECTIVE DISORDERS
- Why do cannabinoid receptors have more than one endogenous ligand?
- (2012) V. Di Marzo et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The endocannabinoid system in anxiety, fear memory and habituation
- (2011) S Ruehle et al. JOURNAL OF PSYCHOPHARMACOLOGY
- (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
- (2011) Kelsey C Duggan et al. Nature Chemical Biology
- Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons
- (2011) Wei Wang et al. NEUROPHARMACOLOGY
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
- (2011) Ebrahim Haroon et al. NEUROPSYCHOPHARMACOLOGY
- Reversible Gating of Endocannabinoid Plasticity in the Amygdala by Chronic Stress: A Potential Role for Monoacylglycerol Lipase Inhibition in the Prevention of Stress-Induced Behavioral Adaptation
- (2011) Joshua J Sumislawski et al. NEUROPSYCHOPHARMACOLOGY
- Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
- (2010) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Plastic Synaptic Networks of the Amygdala for the Acquisition, Expression, and Extinction of Conditioned Fear
- (2010) Hans-Christian Pape et al. PHYSIOLOGICAL REVIEWS
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
- (2009) Andrew H. Miller et al. BIOLOGICAL PSYCHIATRY
- Stress-induced neuroinflammation: mechanisms and new pharmacological targets
- (2009) C.D. Munhoz et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial
- (2009) Shahin Akhondzadeh et al. DEPRESSION AND ANXIETY
- Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain
- (2009) Jian-You Guo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
- (2009) Matthew N. Hill et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started